Chronic Myelomonocytic Leukemia (CMML): High Monocytes, How It Differs From MDS and When Hydroxyurea Is Used
🩸 A routine blood test shows a high monocyte count. It is repeated a few weeks later, and the number is still high. Then the haemoglobin starts to drift down, or the spleen is a little bigger on a scan, and a haematologist uses a term most people have never heard: chronic myelomonocytic leukemia, or CMML. 🔍 It is a rare bone marrow cancer of older adults that sits between two families of disease. Like the myelodysplastic syndromes (MDS), it makes faulty, misshapen blood cells and can cause anaemia, infections and bleeding. Like the myeloproliferative neoplasms, it can push the white count and the spleen up. This guide explains what CMML is, how it differs from classic MDS, how doctors confirm it, why there are two very different types, and how treatment is chosen, from watchful waiting and transfusions to hydroxyurea tablets, azacitidine or decitabine, and stem cell transplant.
🧬 What CMML is, in plain words
🏭 All blood cells are made in the bone marrow from stem cells. In CMML, one early stem cell picks up genetic changes and starts a faulty family of cells that slowly crowds out normal blood production. The marrow becomes busy but inefficient. It makes too many monocytes (a type of white cell that normally cleans up debris and fights infection), while red cells and platelets are often made in too small numbers or with abnormal shapes. 📈 Over months or years, some people stay stable, while in others the disease becomes more aggressive, and in a minority it turns into acute myeloid leukemia (AML).
🔀 Where CMML sits next to MDS
📜 For many years CMML was simply listed as one of the myelodysplastic syndromes. Older textbooks and older web pages still describe five types of MDS: refractory anaemia, refractory anaemia with ring sideroblasts, refractory anaemia with excess blasts, excess blasts in transformation, and CMML. That grouping is out of date. Since the World Health Organization classification of 2001, CMML has been placed in its own group called MDS/MPN overlap neoplasms, because it combines the faulty cell production of MDS with the overproduction typical of myeloproliferative disease. The term “excess blasts in transformation” has also gone; a marrow with 20% blasts or more is now called AML.
👥 Who gets CMML
👴 CMML is uncommon. Most people are over 65 at diagnosis, and men are affected about twice as often as women. In most cases no cause is found. The changes in the marrow appear to build up with age, the same way other age-related blood mutations do. A smaller group develops CMML after earlier chemotherapy or radiotherapy for another cancer; this is called therapy-related disease and tends to behave more aggressively. Smoking and exposure to benzene and some industrial solvents are linked with myeloid cancers in general. CMML is not infectious and is not usually inherited.
🤒 Symptoms people notice
📋 Many people have no symptoms at all and are found through a blood test done for another reason. When symptoms do appear, they come from three directions: low counts, high counts and the inflammation the disease creates. Low red cells cause tiredness and breathlessness, low platelets cause easy bruising and nosebleeds, and poorly working white cells lead to repeated chest or skin infections. High counts and a large spleen cause a feeling of fullness under the left ribs, early satiety after small meals, night sweats, weight loss and low fever.
🧷 Around one in five people with CMML also develops an autoimmune or inflammatory problem, such as vasculitis, inflammatory arthritis, polymyalgia-like pain or skin rashes. These sometimes appear before the blood diagnosis is made, which is one reason a high monocyte count should not be ignored in an older adult with unexplained inflammation.
📊 A high monocyte count: CMML or something else?
🤔 A raised monocyte count is common and is much more often a reaction to something else than a sign of CMML. Doctors first look for the usual reasons, and repeat the test over time. CMML becomes a question only when the monocytosis persists for at least three months without an obvious cause, especially if other counts are abnormal. For a wider look at raised white counts in general, see high white blood cell count: infection, steroids, smoking or a marrow problem.
| 🔎 Cause of monocytosis | 📋 Typical clues |
|---|---|
| Chronic infection | Tuberculosis, endocarditis, brucellosis; fever, cough, heart murmur |
| Recovery after low counts | After chemotherapy or a viral illness, monocytes return first |
| Inflammatory disease | Lupus, sarcoidosis, Crohn disease or ulcerative colitis |
| After spleen removal | Mild lasting rise in several white cell types |
| Other cancers | Lymphoma and some solid tumours can raise monocytes |
| CMML | Persistent rise over 3 months, often with anaemia, low platelets or a big spleen |
🔬 How CMML is diagnosed
🧪 Diagnosis is made by a haematologist and needs several pieces of evidence that fit together. No single blood number is enough. The blood film is examined under a microscope for abnormal monocytes and signs of dysplasia, and a bone marrow sample is taken from the back of the hip bone under local anaesthetic.
📏 The criteria in numbers
📐 Current classifications use a few clear thresholds. The monocyte count must be at least 0.5 x10⁹/L and make up at least 10% of white cells, for at least three months. Blasts (including promonocytes) must be under 20% in blood and marrow, otherwise the diagnosis is AML. Evidence of a clone is also needed, such as dysplasia in the marrow, an abnormal chromosome or a typical mutation. Chronic myeloid leukemia and some rare gene rearrangements must be excluded.
⚖️ Two faces of CMML: dysplastic and proliferative
🔀 Doctors split CMML by the white count at diagnosis, and the split matters for treatment. Below 13 x10⁹/L it is called dysplastic CMML (MD-CMML); at 13 or above it is proliferative CMML (MP-CMML). The dysplastic type behaves much like MDS: the main problems are anaemia and low platelets. The proliferative type behaves more like a myeloproliferative disease, with high counts, a big spleen and general symptoms, and it often carries RAS pathway mutations. It tends to progress faster.
🧬 The genes behind it
🔬 Most people with CMML have a normal-looking set of chromosomes, but almost all have mutations that a modern gene panel can find. The three most frequent are TET2, SRSF2 and ASXL1. RAS pathway genes (NRAS, KRAS, CBL) drive the proliferative picture. Some changes carry a worse outlook, especially ASXL1 changes that truncate the protein, and certain chromosome abnormalities such as trisomy 8 or loss of chromosome 7. These results feed into the risk scores below.
🎯 Risk scores and outlook
📈 CMML ranges from slow and stable to fast and aggressive, so doctors use risk scores to decide how hard to treat. Common tools are the CMML-specific prognostic scoring system (CPSS), its molecular version (CPSS-Mol) and the Mayo molecular model. They combine the white count, blast percentage, transfusion need, haemoglobin, platelets, chromosome results and key mutations. People in the lowest group may live many years with little or no treatment. People in the highest group have a shorter outlook and a higher chance of AML, and are the ones for whom transplant is discussed early.
| 📊 Risk group | 📋 Typical picture | 🩺 Usual approach |
|---|---|---|
| Lower risk | Low blasts, few symptoms, mild anaemia, favourable genes | Watch and wait, treat anaemia, regular counts |
| Lower risk, proliferative | High white count or big spleen, low blasts | Hydroxyurea to control counts and symptoms |
| Higher risk | More blasts, ASXL1 or poor chromosomes, transfusion need | Azacitidine or decitabine; consider transplant |
| Change to AML | 20% blasts or more | Treated as AML |
🕒 Survival figures vary widely between studies and change with newer treatments, so the number that matters is your own risk group, explained by your haematologist, rather than an average from a web page.
👀 Watch and wait
📅 Many people with lower-risk CMML, normal or near-normal counts and no symptoms do not need treatment straight away. Starting chemotherapy early has not been shown to help this group, and every drug has side effects. Instead, blood counts are checked every one to three months, with a physical check of the spleen and a review of symptoms. Treatment starts when there is a clear reason: worsening anaemia, low platelets with bleeding, a rapidly rising white count, a painful spleen, night sweats and weight loss, or rising blasts.
💊 Hydroxyurea for proliferative CMML
💊 Hydroxyurea is an oral chemotherapy capsule that slows the making of new cells in the marrow by blocking an enzyme needed to build DNA. In CMML it is used to bring down a high white count, shrink an enlarged spleen and ease night sweats, fever and weight loss. It does not remove the faulty clone and does not cure the disease, but it is simple, inexpensive, taken at home and usually well tolerated. It has been used for decades in proliferative CMML, and a European trial that compared decitabine with hydroxyurea in advanced proliferative CMML did not show that decitabine gave people longer event-free survival. Hydroxyurea remains a standard first step when high counts are the main problem and blasts are not high.
📋 How it is commonly used
💊 Started at a low dose, often 500 mg to 1 g a day
📊 Dose adjusted up or down by blood counts
📅 Counts checked often at first, then every few weeks
✅ Hydrea (Hydroxyurea) 500 mg capsules
📊 What it changes
✅ High white count: usually controlled
✅ Big spleen: often shrinks
✅ Night sweats, weight loss: often ease
➖ Anaemia: may worsen
❌ Faulty clone, risk of AML: not removed
📖 The same medicine is also used in other marrow diseases with high counts, but the dose, targets and monitoring are always set by a haematologist for the person in front of them. The dose is a balance: enough to control the white count and spleen, but not so much that red cells and platelets drop too far.
📅 Taking hydroxyurea safely day to day
💧 Swallow the capsule whole with water, at about the same time each day. Drink plenty of fluids, especially early on when many cells are breaking down. When the white count is very high and falling quickly, the body releases a lot of uric acid, which can cause gout or harm the kidneys. Some haematologists add Zyloprim (Allopurinol) for the first weeks to keep uric acid down.
⚠️ Hydroxyurea side effects and who should avoid it
| ⚠️ Side effect or situation | 📝 What to know |
|---|---|
| Low blood counts | The most important effect; the reason for regular tests and dose changes |
| Mouth sores, nausea, diarrhoea | Usually mild; tell the team if eating becomes hard |
| Skin and nail changes | Dry skin, darker nails, rash; long use raises skin cancer risk, so use sun protection |
| Leg ulcers | Painful sores near the ankles; may need the drug changed |
| Large red cells (macrocytosis) | Expected and harmless in itself |
| Pregnancy and breastfeeding | Must be avoided; reliable contraception for men and women on treatment |
| Live vaccines | Not given during treatment; ask before any vaccine |
| Kidney problems | Lower doses are needed |
💉 Azacitidine and decitabine
🧪 For higher-risk CMML, or when anaemia and low platelets are the main issue, the standard treatment is a hypomethylating agent. Azacitidine and decitabine switch back on genes that the faulty cells have silenced, which can improve blood counts, reduce transfusion needs and slow progression. Azacitidine is usually given as an injection under the skin for seven days every four weeks; decitabine is given into a vein for five days every four weeks, and an oral tablet combining decitabine with cedazuridine is also available in some countries. These are given in hospital or a day unit, not bought for home use.
Better counts, fewer transfusions, slower progression in some people
At least 4 to 6 cycles before judging whether it works
Lower counts in early cycles, infections, nausea, injection site redness
🤢 Nausea with azacitidine is usually mild and is often prevented with an anti-sickness tablet such as Zofran (Ondansetron) taken before each injection, with constipation as its main side effect to watch for.
🏥 Stem cell transplant: the only cure
🧬 An allogeneic stem cell transplant replaces the marrow with healthy cells from a donor. It is the only treatment that can cure CMML, but it carries real risks: serious infections, graft-versus-host disease and treatment-related death. Because most people with CMML are in their seventies, only a fraction are fit enough. Transplant is usually considered for people with higher-risk disease who are fit, often after a few cycles of a hypomethylating agent to lower the blasts first. Reduced-intensity transplants have made it possible for more older adults to be considered.
🩸 Living with anaemia and transfusions
🔋 Anaemia is the most common problem in CMML, especially in the dysplastic type. Red cell transfusions relieve tiredness and breathlessness quickly, and many people have them every few weeks for years. Some with low transfusion needs respond to erythropoiesis-stimulating agents, injections that push the marrow to make more red cells. People who need many transfusions slowly build up iron in the liver and heart, so ferritin is checked and iron-removing treatment may be offered to those with a good long-term outlook. Platelet transfusions are given for bleeding or before procedures.
Blood count, symptoms, spleen check
Red cell transfusion
Ferritin, kidney and liver tests
Vaccines review, skin check, risk re-score
🦠 Infections: prevention and quick treatment
🛡️ Even with a high white count, the cells in CMML often do not fight germs well, and treatment can push neutrophils down further. Infections are one of the main causes of illness and death in CMML, so prevention and speed matter. Flu and pneumococcal vaccines (not live ones) are recommended, along with good hand hygiene and dental care. During periods of very low neutrophils, for example in early azacitidine cycles or after transplant, haematology teams may prescribe preventive medicines by their own local protocol.
📖 Shingles is a real risk when immunity is low, and early antiviral treatment shortens it; see shingles with a weak immune system and shingles: more than a skin rash. A fever of 38 °C or higher during treatment is an emergency: call the haematology team or go to hospital at once, without waiting to see if it settles.
⚡ When CMML turns into acute leukemia
📈 A minority of people with CMML, more often those with higher blasts or adverse genes, develop AML over time. Warning signs are a sudden fall in counts, rising blasts on the blood film, new fevers, bone pain or rapid tiredness. AML arising from CMML is usually harder to treat than AML that starts in a previously healthy marrow, so regular monitoring is aimed at catching the change early. Treatment then follows AML pathways; an older overview of the disease is in what acute leukemia is and how it is treated.
🍽️ Everyday life with CMML
🚶 Most people with lower-risk CMML continue their usual lives between clinic visits. Small habits help: light daily activity to fight fatigue, a balanced diet with enough protein, food safety when counts are low (well-cooked meat and eggs, washed vegetables), a soft toothbrush when platelets are low, and avoiding contact sports or heavy lifting when the spleen is large. Alcohol in moderation, no smoking, and keeping a simple diary of counts, transfusions and symptoms makes clinic visits more useful.
🗿 Myths about CMML
🗣️ Questions to ask your haematologist
📝 Bring this list to the next appointment:
🔹 Is my CMML dysplastic or proliferative, and is it CMML-1 or CMML-2?
🔹 What is my risk group, and which mutations were found?
🔹 What would make you start treatment, and what would it be?
🔹 Am I a possible transplant candidate, and should my siblings be tested as donors?
🔹 What fever level or symptoms should make me call you, and what number do I use at night?
🔹 Are there clinical trials I could join?
🚨 When to see a doctor urgently
⛔ Get medical help the same day if you have CMML or are on hydroxyurea and notice:
🔹 A temperature of 38 °C or higher, shivering, or feeling suddenly very unwell.
🔹 Bleeding that does not stop, blood in urine or stool, or many new bruises.
🔹 Sudden pain in the left upper belly or left shoulder, which can mean a problem with the spleen.
🔹 Severe breathlessness, chest pain, confusion or fainting.
🔹 Painful sores in the mouth that stop you eating or drinking, or a new ulcer on the leg.
📞 Keep the haematology contact number in your phone and wallet. If you go to an emergency department, tell the staff straight away that you have CMML and which medicines you take, so they check your blood count and treat a possible infection quickly.
❓ Frequently asked questions
Is CMML a type of myelodysplastic syndrome?
It used to be listed as one. Since 2001 it has been classed as an MDS/MPN overlap neoplasm, because it combines faulty cell production with overproduction of monocytes.
What monocyte count suggests CMML?
A count of at least 0.5 x10^9/L making up 10% or more of white cells, lasting at least three months, with no other cause and with signs of a marrow clone.
Can a high monocyte count be harmless?
Yes. Infections, inflammatory diseases, recovery after low counts and spleen removal are far more common causes than CMML.
What is the difference between dysplastic and proliferative CMML?
Dysplastic CMML has a white count under 13 x10^9/L and mainly causes low counts. Proliferative CMML has a higher count, often a big spleen and general symptoms.
Why is hydroxyurea used in CMML?
It lowers a high white count, can shrink an enlarged spleen and eases night sweats and weight loss. It controls the disease but does not cure it.
How often are blood tests needed on hydroxyurea?
Often every week or two at the start, then every few weeks, and every one to three months once the dose is stable.
When are azacitidine or decitabine used?
Mainly in higher-risk CMML or when low counts are the main problem. They are given in cycles in hospital, and several cycles are needed to judge the effect.
Can CMML be cured?
Only an allogeneic stem cell transplant can cure it. It is offered to fit people, usually with higher-risk disease, because it carries serious risks.
Does CMML always turn into acute leukemia?
No. A minority progress to AML, more often those with higher blasts or adverse mutations. Regular monitoring is aimed at catching it early.
What should I do if I get a fever with CMML?
A temperature of 38 C or higher is an emergency, especially during treatment. Call the haematology team or go to hospital at once.
📑 Sources and editorial
- 📘 Current international classifications of myeloid neoplasms, including MDS/MPN overlap disease
- 🧬 Reviews of the genetics of CMML and of CMML-specific prognostic scoring systems
- 💊 Prescribing information and haematology guidance on hydroxyurea
- 💉 Clinical trials of azacitidine, decitabine and hydroxyurea in CMML
- 🏥 Expert recommendations on stem cell transplant in MDS/MPN
- 🦠 Guidelines on infection prevention and fever management in patients with low neutrophils
- 📖 Related reading: high white blood cell count, acute leukemia, shingles with a weak immune system, shingles
- 🛒 Related products: Hydrea (Hydroxyurea), Zyloprim (Allopurinol), Zofran (Ondansetron), Levaquin (Levofloxacin), Cipro (Ciprofloxacin), Fluconaz (Fluconazole), Zovirax (Acyclovir), Valtrex (Valacyclovir)
- 🩺 RXshop Editorial Team — reviewed by Emily Chen, MD — Internal medicine
Medical Disclaimer: The information in this article is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek guidance from a qualified healthcare provider with any questions you may have regarding a medical condition, and before starting, stopping or changing any medication.